238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
26.61%
Revenue growth of 26.61% while BIDU is flat. Bruce Berkowitz would check if a small edge can widen further.
14.04%
Gross profit growth of 14.04% while BIDU is zero. Bruce Berkowitz would see if minimal improvements could expand further.
-36.06%
Negative EBIT growth while BIDU is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-36.06%
Negative operating income growth while BIDU is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-37.83%
Negative net income growth while BIDU stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-17.39%
Negative EPS growth while BIDU is at 10.55%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-17.39%
Negative diluted EPS growth while BIDU is at 10.55%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-24.95%
Share reduction while BIDU is at 11.44%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-26.21%
Reduced diluted shares while BIDU is at 11.44%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
106.25%
OCF growth of 106.25% while BIDU is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
121.21%
FCF growth of 121.21% while BIDU is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
171.62%
10Y CAGR of 171.62% while BIDU is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
171.62%
5Y CAGR of 171.62% while BIDU is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
171.62%
3Y CAGR of 171.62% while BIDU is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-39.79%
Negative 10Y net income/share CAGR while BIDU is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-39.79%
Negative 5Y net income/share CAGR while BIDU is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-39.79%
Negative 3Y CAGR while BIDU is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
340.20%
R&D growth of 340.20% while BIDU is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
No Data
No Data available this quarter, please select a different quarter.